Tag: Guest Bloggers

Weekly Futures Recap w/Michael Seery

Posted on by The INO.com Team

We’ve asked Michael Seery of SEERYFUTURES.COM to give our INO readers a weekly recap of the Futures market. He has been Senior Analyst for close to 15 years and has extensive knowledge of all of the commodity and option markets.

Michael frequently appears on multiple business networks including Bloomberg news, Fox Business, CNBC Worldwide, CNN Business, and Bloomberg TV. He is also a guest on First Business, which is a national and internationally syndicated business show.

Grain Futures--- The grain market this week saw high volatility across the board especially on this Friday afternoon with many commodities selling off sharply today putting pressure on the soybeans in the January contract finishing down only 11 cents at 15.35 a bushel up around $.13 for the trading week right near the 20 day and 100 day moving averages which is at 15.51 a bushel and in my opinion if prices break those levels on heavy volume the lows might be in the soybean market. Corn futures for the December contract were one of the few commodities today that were actually higher trading at 7.61 a bushel right near a four week after last Thursday’s bullish report has propelled corn prices at the upper end of the trading range. That corn is far above their 20 and 100 day moving average which suggests to me in my opinion that prices are headed towards the $8 dollar level with wheat having a very solid week up $.18 and on this Friday afternoon closing higher by $.3 at 8.71 a bushel breaking its 20 day moving average which was at 8 .70 and well above its 100 day moving averages which looks to me that it is going to rally along with corn and the oat market. Wheat futures for the December contract are down about 7% from the high which was a July 23, 2012 at 9.53 a bushel which was during the summer drought. In my opinion I believe the soybeans are in a bottoming process after dropping over $2.50 from recent highs due to harvest pressure as well as a major slowdown in China sending many of the grain prices off of their summer highs with better than expected yields coming in putting a lid on prices at this point, however about 75% of the soybean crop is harvested which means most of the harvest pressure has finished. Traders are now focusing on the November 9th crop report and the weather in South America with the growing season underway receiving beneficial rains and normal temperatures which means the crop is off to a solid start which could be a record producing year in Brazil and in Argentina. Continue reading "Weekly Futures Recap w/Michael Seery" →

What Moves Biotech Stocks? Ed Arce Has Answers.

Posted on by admin

The Life Sciences Report: Your experience is very broad. Just four or five years ago, you were a big pharma analyst at a major investment bank, where you followed the largest drug makers in the world. From your perspective today, as an analyst following small-cap biotech and medtech, can you talk about the clinical assets that drive value in smaller companies?

Ed Arce: From a market perspective, the key value drivers largely remain the same. First, and by far most important, are the clinical data. The stronger the efficacy, the better. But meeting clinical endpoints needs to translate into a clinically meaningful benefit. An outright therapeutic cure is optimal, but is also quite rare. Also, the overall safety and tolerability profile of any new therapeutic must be commensurate with the severity of the disease, and comparable to the risk profiles of any existing pharmacotherapies. Risk/benefit is obviously a trade-off. The U.S. Food and Drug Administration (FDA), in attempting to balance the risk/benefit equation, has leaned a bit in one direction or the other over the years.

The second point, from a market perspective, is the size of the patient population and the degree to which that population has been, or is, treatment nave.

The third point is value driven by a long product life, in the form of a long-dated patent suite, as well as any regulatory exclusivity offered to the drug. Continue reading "What Moves Biotech Stocks? Ed Arce Has Answers." →

Brent Cook and Quinton Hennigh Use Geology to Find Winners

Posted on by admin

The Gold Report: Brent, Quinton recently joined Exploration Insights. What does Quinton bring to the publication?

Brent Cook: Quinton is a geologist who can see the big picture. He focuses on how a mineral deposit forms and assesses if it is economic. His contributions allow us to cover a lot more ground in the same time and our discussions often refine and improve the final investment decisions. It's a whole aspect to the business that's going to help me make Exploration Insights better. Given the state of the junior mining sector, this is the time to be picking up the deposits and companies that are undervalued or that show potential value based on a real economic evaluation.

"Because this is such a high-risk game, we're mostly looking for homeruns."

Quinton came out of Newmont Mining Corp. (NEM:NYSE) and Newcrest Mining Ltd. (NCM:ASX). He knows how the big companies work and what their investment criteria are. Ultimately, our goal at Exploration Insights is to identify deposits that are going to have high enough margins and be large enough to attract a buyout or purchase from a major mining company. Quinton did that at Newmont. Continue reading "Brent Cook and Quinton Hennigh Use Geology to Find Winners" →

Bruno del Ama: Do ETFs Offer Value for MLPs?

Posted on by admin

The Energy Report: Bruno, since Global X Funds brought its first exchange-traded fund (ETF) to market in 2009, you have added another 30, the latest being the Global X MLP ETF (MLPA:NYSE). What is the appetite among investors for ETFs, and specifically those featuring master limited partnerships (MLPs)?

Bruno del Ama: Investors continue to migrate to the ETF asset class, and we are big fans of energy MLPs. Energy transportation is an infrastructure play with a couple of benefits. First, it provides significant diversification to complement investors' portfolios; second, it provides income in a low-interest rate environment.

ETFs are an innovation in the MLP asset class. We at Global X focus on asset classes where we are the first provider of a particular ETF. In our last interview, for example, we talked about our uranium ETF, which provides focused exposure to that market in a way that did not exist before. Innovation is in our DNA. Continue reading "Bruno del Ama: Do ETFs Offer Value for MLPs?" →

What Will the Price of Gold Be in January 2014?

Posted on by The INO.com Team

By Jeff Clark, Casey Research

While many of us at Casey Research don't like making price predictions, and certainly ones accompanied by a specific date, it's hard to ignore the correlation between the US monetary base and the gold price.

That correlation says we'll see $2,300 gold by January 2014.

There are plenty of long-term charts that show a connection between gold and various other forms of money (and credit). Most show that one outperforms until the other catches up. But let's zero in on our current circumstances, namely the expansion of the US monetary base since the financial crisis hit in 2008.

Here's the performance of the gold price compared to the expansion of the monetary base since January 2008. Continue reading "What Will the Price of Gold Be in January 2014?" →